IP Library Granted Patent US 6,974,863
Granted Patent B2
US 6,974,863 · App. 10/067,122 · Granted Dec 13, 2005

Antibody for 4-1BB

Assignee: Indiana University Research and technology Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,974,863
App. No.
10/067,122
Granted
Dec 13, 2005
Kind
B2
Abstract

The present invention includes the receptor protein 4-1BB and the cDNA gene encoding for receptor protein 4-1BB. The nucleotide sequence of the isolated cDNA is disclosed herein along with the deduced amino acid sequence. The 4-1BB protein and fragments and derivatives can be used: 1) as a probe to isolate ligands to receptor protein 4-1BB, 2) to stimulate proliferation of B-cell's expressing 4-1BB, or 3) to block 4-1BB ligand binding. A monoclonal antibody against 4-1BB was developed which specifically recognizes an epitope on the extracellular domain of receptor protein 4-1BB. The monoclonal antibody can be used enhance T-cell proliferation and activation by treating T-cells that have expressed receptor protein 4-1BB with the monoclonal antibody. The effectiveness of the treatment was enhanced when conducted in the presence of protein tyrosinase kinase. A fusion protein for detecting cell membrane ligands to receptor protein 4-1BB was developed. It comprises the extracellular portion of the receptor protein 4-1BB and a detection protein bound to the portion of the receptor protein 4-1BB.

Claims (7)

1. An isolated antibody that binds to mouse receptor protein 4-1BB comprising the amino acid sequence of SEQ ID NO:2.

2. The antibody of claim 1 wherein said antibody is produced from a hybridoma identified as 53A2 and deposited at the American Type Culture Collection under ATCC No.: HB-11248.

3. A hybridoma capable of producing an antibody of claim 1 .

4. The hybridoma of claim 3 wherein said hybridoma is identified as 53A2 and deposited at the American Type Culture Collection under ATCC No.: HB-11248.

5. The antibody of claim 1 , wherein said antibody is polyclonal.

6. The antibody of claim 5 which specifically binds to an epitope comprising amino acid residues 105-115 or 133-157 of SEQ ID NO:2.

7. The antibody of claim 1 , wherein said antibody is monoclonal.

Assignments (2)
EXECUTIVE ORDER 9424, CONFIRMATORY LICENSE Recorded May 21, 2008
From: INDIANA UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 020975/0933 →
CHANGE OF NAME Recorded Mar 29, 2005
From: ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC.
To: INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORPORATION
Reel/Frame 015829/0582 →
Continuity (3)
Division 0801226900 · Feb 1, 1993
Continuation In Part 0792299600 · Jul 30, 1992
Related Publication 20030100745A1 · May 29, 2003